Dominic Spadafore

Dominic Spadafore serves as the Chief Executive Officer of Prolira, a medical device company specializing in the diagnostic of acute encephalopathy associated with delirium, since March 2023. Additionally, Dominic holds a board member position at Sirius Medical and is the Principal at Dominic Spadafore and Associates LLC since October 2012. Previous roles include President of U.S. operations at The Surgical Company Group, Executive Chairman at New Vital Signs Inc., and President and CEO at Acousys Biodevices Inc. Dominic's experience also encompasses leadership positions in global marketing, sales, and market development at BMEYE, Covidien, Somanetics Corporation, and Datascope Cardiac Assist. Dominic holds a B.S. in Biology from Oakland University.